2,994
回編集
差分
ナビゲーションに移動
検索に移動
ページの作成:「==NTDs== *preventative chemoTx and transmission control (PCT) ones **mass drug administration ***onchocerciasis ***lympahatic filariasis ***schistosomiasis ***soil-transm…」
==NTDs==
*preventative chemoTx and transmission control (PCT) ones
**mass drug administration
***onchocerciasis
***lympahatic filariasis
***schistosomiasis
***soil-transmitted helminths
*innovative and intensified disease management (IDM) ones
**individual care findings and case management
***leishmaniasis
***buruli ulcer
***mycetoma
***yaws
****azithromycin is turning yaws to PCT
***scabies
****ivermectin is turning scabies to PCT
***...
==skin NTDs==
*new movement to integrate disease controls between NTDs that manifest with skin symptoms
**led by WHO and community dermatologists
==exanthematology==
*morphology of each rash
*distribution
==leprosy==
*''Mycobacterium leprae''
*20,000-25,000 new cases/year
**mostly in India
*respiratory transmission? difficult to determine because of long incubation period
*skin + peripheral nerve manifestation
*clinical manifestation differs in wide range depending on amount of bacilli and host immune response
*WHO classification
**MB - multibacillary > 5 lesions
***multi-drug Tx for 1 year
**PB - paucibacillary 2-5 lesions
***multi-drug Tx for 6 months
**single lesion
***single dose
*Rideley & Jpling classification
**TT
**BT
**BB
**BL
**LL
*preventative chemoTx and transmission control (PCT) ones
**mass drug administration
***onchocerciasis
***lympahatic filariasis
***schistosomiasis
***soil-transmitted helminths
*innovative and intensified disease management (IDM) ones
**individual care findings and case management
***leishmaniasis
***buruli ulcer
***mycetoma
***yaws
****azithromycin is turning yaws to PCT
***scabies
****ivermectin is turning scabies to PCT
***...
==skin NTDs==
*new movement to integrate disease controls between NTDs that manifest with skin symptoms
**led by WHO and community dermatologists
==exanthematology==
*morphology of each rash
*distribution
==leprosy==
*''Mycobacterium leprae''
*20,000-25,000 new cases/year
**mostly in India
*respiratory transmission? difficult to determine because of long incubation period
*skin + peripheral nerve manifestation
*clinical manifestation differs in wide range depending on amount of bacilli and host immune response
*WHO classification
**MB - multibacillary > 5 lesions
***multi-drug Tx for 1 year
**PB - paucibacillary 2-5 lesions
***multi-drug Tx for 6 months
**single lesion
***single dose
*Rideley & Jpling classification
**TT
**BT
**BB
**BL
**LL
